Member Info for Bobat123

European Patent Office has granted a European Patent for its innovative CellKeep™ slide. A formal communication has also been received from the United States Patent and Trademark Office indicating that grant of the equivalent US patent application is imminent. News due soon

ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.

ANGLE's commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. The clinical services business is offered through ANGLE's GCP-compliant laboratories. Services include custom made assay development and clinical trial testing for pharma.

Over 90 peer-reviewed publications have demonstrated the performance of the Parsortix system. For more information, visit www.angleplc.com

MMs taking the shares on the cheap and peeps are paying over premium to load up before delist.

There is also a distressed seller offloading for the past few days . Hopefully should be TR1 soon. That is what is also holding this back

Since the RNS there has been 480K buy and also other big buys. Mms have been filling order.

Https://www.lse.co.uk/ShareBrokerTips.html?shareprice=AGL&share=Angle

Broker Rating 70p

100000 buy printed. Peeps loading up before delist

Watch out for big buys out of hours. Many peeps have sold out on. Loss.

Code 1 printed for the believers. Rns due most probably TR1 on seller

Lol. Derampers trying their best to get this down.

Mms taking shares on the cheap and selling at premium

Brokers rating 70. Follow the money

Buy printed 434425. For £67.83k

24-Apr-24 16:32:43 15.61439 434,425 67.83k

Buy printed 434425. For £67.83

24-Apr-24 16:32:43 15.61439 434,425 67.83k

Elsewhere, medical diagnostics provider Angle jumped 28% after it said it has signed a supplier agreement with FTSE 100-listed pharmaceutical firm AstraZeneca.

The AIM listing explained that the contract is to develop and validate a methodology leveraging Angle's existing DNA damage response assay for the detection of micronuclei in CTCs as a measure of DDR.

Chief Executive Andrew Newland commented: "This is Angle's second large pharma company agreement of 2024 as we look to drive a significant expansion of the pharma services business. It demonstrates the importance of CTC analysis and is a validation of Angle's Parsortix system. Angle is also working to expand its DDR work with other large pharma customers and continues to generate significant new customer interest through its business development activity."

Https://www.lse.co.uk/ShareBrokerTips.html?shareprice=AGL&share=Angle

Broker Rating 70p

Mms trying their best to not let 17 go. Once 17 is gone mms will be scrapping for shares

1 mm waiting on 22. Brakes off

No placing funded till 2025. . Scare Mongering peeps trying to talk this down. Get a life

NT to buy. Mms holding it down for mates rates